Metraipolis › archive › dc_2e457fb417d9

Clinical Characteristics and Outcomes of Patients Undergoing Transcatheter Tricuspid Valve Replacement Stratified by TRISCEND II Trial Eligibility — Europe PMC PMID:42111092

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42111092
DOI
10.1016/j.jscai.2026.104385
License (as archived)
solo-consultazione
Archived
2026-11-04T01:18:30.655Z
SHA-256 of the archived text
71577e1af30842c7d290232205a72aad39433fa6dc3eda8fec09643c905ba462
Stable URL of this page
https://metraipolis.com/documento/dc_2e457fb417d9

How to cite

Clinical Characteristics and Outcomes of Patients Undergoing Transcatheter Tricuspid Valve Replacement Stratified by TRISCEND II Trial Eligibility — Europe PMC PMID:42111092 — Europe PMC (en), https://europepmc.org/article/MED/42111092 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2e457fb417d9 (Metraipolis archive dc_2e457fb417d9, sha256 71577e1af30842c7d290232205a72aad39433fa6dc3eda8fec09643c905ba462)
BibTeX
@misc{dc2e457fb417d9,
  title = {Clinical Characteristics and Outcomes of Patients Undergoing Transcatheter Tricuspid Valve Replacement Stratified by TRISCEND II Trial Eligibility — Europe PMC PMID:42111092},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42111092},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2e457fb417d9; sha256 71577e1af30842c7d290232205a72aad39433fa6dc3eda8fec09643c905ba462},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42111092. Agents can read the archived copy with the MCP tool read_document.